In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML:: results from a prospective phase II study

被引：16

作者：

Bonifazi, F ^{[1
]}

Bandini, G ^{[1
]}

Stanzani, M ^{[1
]}

Palandri, F ^{[1
]}

Giannini, B ^{[1
]}

Arpinati, M ^{[1
]}

Rosti, G ^{[1
]}

Baccarani, M ^{[1
]}

机构：

[1] Univ Bologna, S Orsola M Malpighi Hosp, Inst Hematol L&A Seragnoli, Bologna, Italy

来源：

BONE MARROW TRANSPLANTATION | 2005年 / 35卷 / 10期

关键词：

D O I：

10.1038/sj.bmt.1704940

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1025 / 1026

页数：2

共 10 条

[1] Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) [J].

Bacigalupo, A ;

Lamparelli, T ;

Bruzzi, P ;

Guidi, S ;

Alessandrino, PE ;

di Bartolomeo, P ;

Oneto, R ;

Bruno, B ;

Barbanti, M ;

Sacchi, N ;

Van Lint, MT ;

Bosi, A .

BLOOD, 2001, 98 (10) :2942-2947

[2] Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML [J].

Bonifazi, F ;

Bandini, G ;

Rondelli, D ;

Falcioni, S ;

Stanzani, M ;

Bontadini, A ;

Tazzari, PL ;

Arpinati, M ;

Giannini, B ;

Conte, R ;

Baccarani, M .

BONE MARROW TRANSPLANTATION, 2003, 32 (03) :237-242

[3] Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia [J].

Elmaagacli, AH ;

Basoglu, S ;

Peceny, R ;

Trenschel, R ;

Ottinger, H ;

Lollert, A ;

Runde, V ;

Grosse-Wilde, H ;

Beelen, DW ;

Schaefer, UW .

BLOOD, 2002, 99 (04) :1130-1135

[4] Transplantation in chronic myeloid leukaemia [J].

Gratwohl, A ;

Baldomero, H ;

Urbano-Ispizua, A .

LANCET, 2002, 359 (9307) :712-713

[5] In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors [J].

Kröger, N ;

Zabelina, T ;

Krüger, W ;

Renges, H ;

Stute, N ;

Rischewski, J ;

Sonnenberg, S ;

Ayuk, F ;

Tögel, F ;

Schade, U ;

Fiegel, H ;

Erttmann, R ;

Löliger, C ;

Zander, AR .

BONE MARROW TRANSPLANTATION, 2002, 29 (08) :683-689

[6] Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study [J].

Mohty, M ;

Kuentz, M ;

Michallet, M ;

Bourhis, JH ;

Milpied, N ;

Sutton, L ;

Jouet, JP ;

Attal, M ;

Bordigoni, P ;

Cahn, JY ;

Boiron, JM ;

Blaise, D .

BLOOD, 2002, 100 (09) :3128-3134

[7]

Pistillo MP, 2002, TRANSPLANTATION, V73, P1295

[8] Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation [J].

Remberger, M ;

Svahn, BM ;

Hentschke, P ;

Löfgren, C ;

Ringdén, O .

BONE MARROW TRANSPLANTATION, 1999, 24 (08) :823-830

[9] Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation -: a retrospective analysis [J].

Schetelig, J ;

Bornhäuser, M ;

Kiehl, M ;

Schwerdtfeger, R ;

Kröger, N ;

Runde, V ;

Zabelina, T ;

Held, TK ;

Thiede, C ;

Fauser, AA ;

Beelen, D ;

Zander, A ;

Ehninger, G ;

Siegert, W .

BONE MARROW TRANSPLANTATION, 2004, 33 (05) :483-490

[10] Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML [J].

Schleuning, M ;

Günther, W ;

Tischer, J ;

Ledderose, G ;

Kolb, HJ .

BONE MARROW TRANSPLANTATION, 2003, 32 (03) :243-250

← 1 →